140 related articles for article (PubMed ID: 10027857)
1. [3H]gemcitabine uptake by nucleoside transporters in a human head and neck squamous carcinoma cell line.
Hammond JR; Lee S; Ferguson PJ
J Pharmacol Exp Ther; 1999 Mar; 288(3):1185-91. PubMed ID: 10027857
[TBL] [Abstract][Full Text] [Related]
2. Interaction of 2',2'-difluorodeoxycytidine (gemcitabine) and formycin B with the Na+-dependent and -independent nucleoside transporters of Ehrlich ascites tumor cells.
Burke T; Lee S; Ferguson PJ; Hammond JR
J Pharmacol Exp Ther; 1998 Sep; 286(3):1333-40. PubMed ID: 9732397
[TBL] [Abstract][Full Text] [Related]
3. 5-hexyl-2'-deoxyuridine inhibition of nucleoside transport in L1210 cells.
Cory JG; Downes DL; Ng CY; Belt JA
Oncol Res; 1992; 4(4-5):175-9. PubMed ID: 1504377
[TBL] [Abstract][Full Text] [Related]
4. Uptake and release of [3H]formycin B via sodium-dependent nucleoside transporters in mouse leukemic L1210/MA27.1 cells.
Borgland SL; Parkinson FE
J Pharmacol Exp Ther; 1997 Apr; 281(1):347-53. PubMed ID: 9103516
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters.
Mackey JR; Yao SY; Smith KM; Karpinski E; Baldwin SA; Cass CE; Young JD
J Natl Cancer Inst; 1999 Nov; 91(21):1876-81. PubMed ID: 10547395
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.
Gourdeau H; Clarke ML; Ouellet F; Mowles D; Selner M; Richard A; Lee N; Mackey JR; Young JD; Jolivet J; Lafrenière RG; Cass CE
Cancer Res; 2001 Oct; 61(19):7217-24. PubMed ID: 11585758
[TBL] [Abstract][Full Text] [Related]
7. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines.
Mackey JR; Mani RS; Selner M; Mowles D; Young JD; Belt JA; Crawford CR; Cass CE
Cancer Res; 1998 Oct; 58(19):4349-57. PubMed ID: 9766663
[TBL] [Abstract][Full Text] [Related]
8. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
[TBL] [Abstract][Full Text] [Related]
9. L1210/B23.1 cells express equilibrative, inhibitor-sensitive nucleoside transport activity and lack two parental nucleoside transport activities.
Vijayalakshmi D; Dagnino L; Belt JA; Gati WP; Cass CE; Paterson AR
J Biol Chem; 1992 Aug; 267(24):16951-6. PubMed ID: 1512237
[TBL] [Abstract][Full Text] [Related]
10. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
Hammond JR
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
[TBL] [Abstract][Full Text] [Related]
11. Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells.
Hioki M; Shimada T; Yuan T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Sawamoto K; Akashita G; Miyamoto KI; Ohta T; Tamai I; Shimada T; Sai Y
Biopharm Drug Dispos; 2018 May; 39(5):256-264. PubMed ID: 29682747
[TBL] [Abstract][Full Text] [Related]
12. Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes.
Lostao MP; Mata JF; Larrayoz IM; Inzillo SM; Casado FJ; Pastor-Anglada M
FEBS Lett; 2000 Sep; 481(2):137-40. PubMed ID: 10996312
[TBL] [Abstract][Full Text] [Related]
13. Saturable Hepatic Extraction of Gemcitabine Involves Biphasic Uptake Mediated by Nucleoside Transporters Equilibrative Nucleoside Transporter 1 and 2.
Shimada T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Shimada T; Sawamoto K; Miyamoto K; Kitagawa H; Ohta T; Tamai I; Sai Y
J Pharm Sci; 2015 Sep; 104(9):3162-9. PubMed ID: 26037416
[TBL] [Abstract][Full Text] [Related]
14. Differential uptake of [3H]guanosine by nucleoside transporter subtypes in Ehrlich ascites tumour cells.
Hammond JR
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):431-6. PubMed ID: 1445201
[TBL] [Abstract][Full Text] [Related]
15. Erlotinib, gefitinib, and vandetanib inhibit human nucleoside transporters and protect cancer cells from gemcitabine cytotoxicity.
Damaraju VL; Scriver T; Mowles D; Kuzma M; Ryan AJ; Cass CE; Sawyer MB
Clin Cancer Res; 2014 Jan; 20(1):176-86. PubMed ID: 24170548
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacology of the nitrobenzylthioguanosine-sensitive and -resistant nucleoside transport mechanisms of Ehrlich ascites tumor cells.
Hammond JR
J Pharmacol Exp Ther; 1991 Nov; 259(2):799-807. PubMed ID: 1941627
[TBL] [Abstract][Full Text] [Related]
17. Nucleoside transport in brush border membrane vesicles from human kidney.
Gutierrez MM; Brett CM; Ott RJ; Hui AC; Giacomini KM
Biochim Biophys Acta; 1992 Mar; 1105(1):1-9. PubMed ID: 1567888
[TBL] [Abstract][Full Text] [Related]
18. Characterization of equilibrative and concentrative Na+-dependent (cif) nucleoside transport in acute promyelocytic leukemia NB4 cells.
Roovers KI; Meckling-Gill KA
J Cell Physiol; 1996 Mar; 166(3):593-600. PubMed ID: 8600163
[TBL] [Abstract][Full Text] [Related]
19. High-affinity, equilibrative nucleoside transporter of pig kidney cell line (PK-15).
Aran JM; Plagemann PG
Biochim Biophys Acta; 1992 Jul; 1108(1):67-74. PubMed ID: 1379470
[TBL] [Abstract][Full Text] [Related]
20. Purine uptake and release in rat C6 glioma cells: nucleoside transport and purine metabolism under ATP-depleting conditions.
Sinclair CJ; LaRivière CG; Young JD; Cass CE; Baldwin SA; Parkinson FE
J Neurochem; 2000 Oct; 75(4):1528-38. PubMed ID: 10987833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
